Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer
Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So,
identification of potential molecular signatures is required for diagnosis, prognosis, and …
identification of potential molecular signatures is required for diagnosis, prognosis, and …
Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer.
MB Hossen, MA Islam, MS Reza, MK Kibria… - Computers in Biology …, 2022 - europepmc.org
Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So,
identification of potential molecular signatures is required for diagnosis, prognosis, and …
identification of potential molecular signatures is required for diagnosis, prognosis, and …
Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer
MB Hossen, MA Islam, MS Reza… - … in biology and …, 2023 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So,
identification of potential molecular signatures is required for diagnosis, prognosis, and …
identification of potential molecular signatures is required for diagnosis, prognosis, and …
Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer
MB Hossen, MA Islam, MS Reza, MK Kibria… - 2023 - dl.acm.org
Pancreatic cancer (PC) is one of the leading causes of cancer-related death globally. So,
identification of potential molecular signatures is required for diagnosis, prognosis, and …
identification of potential molecular signatures is required for diagnosis, prognosis, and …